Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4l34 | 1VG | Tankyrase-2 | 2.4.2.30 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4l34 | 1VG | Tankyrase-2 | 2.4.2.30 | 1.000 | |
| 4l0t | 1V0 | Tankyrase-2 | 2.4.2.30 | 0.706 | |
| 3kr8 | XAV | Tankyrase-2 | 2.4.2.30 | 0.631 | |
| 4l10 | A63 | Tankyrase-2 | 2.4.2.30 | 0.613 | |
| 4hlg | 20B | Tankyrase-2 | 2.4.2.30 | 0.593 | |
| 4buu | F38 | Tankyrase-2 | 2.4.2.30 | 0.561 | |
| 4bux | F35 | Tankyrase-2 | 2.4.2.30 | 0.556 | |
| 4kzu | A73 | Tankyrase-2 | 2.4.2.30 | 0.542 | |
| 4j22 | AJ7 | Tankyrase-2 | 2.4.2.30 | 0.532 | |
| 4l0s | 1UZ | Tankyrase-2 | 2.4.2.30 | 0.531 | |
| 4bu9 | 08C | Tankyrase-2 | 2.4.2.30 | 0.530 | |
| 4hlk | 431 | Tankyrase-2 | 2.4.2.30 | 0.528 | |
| 4but | 31F | Tankyrase-2 | 2.4.2.30 | 0.526 | |
| 4bui | W2E | Tankyrase-2 | 2.4.2.30 | 0.525 | |
| 4hkn | LU2 | Tankyrase-2 | 2.4.2.30 | 0.525 | |
| 4l31 | F08 | Tankyrase-2 | 2.4.2.30 | 0.523 | |
| 4hlh | 20D | Tankyrase-2 | 2.4.2.30 | 0.518 | |
| 4buf | F36 | Tankyrase-2 | 2.4.2.30 | 0.517 | |
| 4hkk | AGI | Tankyrase-2 | 2.4.2.30 | 0.517 | |
| 4bud | 29F | Tankyrase-2 | 2.4.2.30 | 0.510 | |
| 4bue | JQF | Tankyrase-2 | 2.4.2.30 | 0.497 | |
| 4bus | 32F | Tankyrase-2 | 2.4.2.30 | 0.491 | |
| 4iue | AJ4 | Tankyrase-2 | 2.4.2.30 | 0.455 | |
| 4l0i | 1UW | Tankyrase-2 | 2.4.2.30 | 0.452 | |
| 4l2k | 1V8 | Tankyrase-2 | 2.4.2.30 | 0.448 | |
| 5aku | 29F | Tankyrase-2 | 2.4.2.30 | 0.448 | |
| 4l33 | F70 | Tankyrase-2 | 2.4.2.30 | 0.447 | |
| 4l0v | 1V1 | Tankyrase-2 | 2.4.2.30 | 0.440 |